These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 30333226)
1. A dynamic transcriptomic atlas of cytokine-induced killer cells. Meng M; Li L; Li R; Wang W; Chen Y; Xie Y; Han R; Zhu K; Huang W; Yang L; Li S; Shi J; Tan W; Gao H; Zhao Y; Yang L; Tan J; Hou Z J Biol Chem; 2018 Dec; 293(51):19600-19612. PubMed ID: 30333226 [TBL] [Abstract][Full Text] [Related]
2. Global transcriptome-wide analysis of CIK cells identify distinct roles of IL-2 and IL-15 in acquisition of cytotoxic capacity against tumor. Wang W; Meng M; Zhang Y; Wei C; Xie Y; Jiang L; Wang C; Yang F; Tang W; Jin X; Chen D; Zong J; Hou Z; Li R BMC Med Genomics; 2014 Aug; 7():49. PubMed ID: 25108500 [TBL] [Abstract][Full Text] [Related]
3. [Killing activity of co-cultured cytokine-induced killer cells and dendritic cells against multi-drug resistant tumor cell lines]. Li SJ; Zhang LS; Chai Y; Zhang YF; Zhang YM; Zeng PY; Wu CY Zhonghua Zhong Liu Za Zhi; 2007 Oct; 29(10):733-7. PubMed ID: 18396683 [TBL] [Abstract][Full Text] [Related]
4. Increase in Efficacy of Checkpoint Inhibition by Cytokine-Induced-Killer Cells as a Combination Immunotherapy for Renal Cancer. Dehno MN; Li Y; Weiher H; Schmidt-Wolf IGH Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32349280 [TBL] [Abstract][Full Text] [Related]
5. Dendritic cells infected by Ad-sh-SOCS1 enhance cytokine-induced killer (CIK) cell immunotherapeutic efficacy in cervical cancer models. Zheng Y; Hu B; Xie S; Chen X; Hu Y; Chen W; Li S; Hu B Cytotherapy; 2017 May; 19(5):617-628. PubMed ID: 28215653 [TBL] [Abstract][Full Text] [Related]
6. Immune checkpoint inhibitors enhance cytotoxicity of cytokine-induced killer cells against human myeloid leukaemic blasts. Poh SL; Linn YC Cancer Immunol Immunother; 2016 May; 65(5):525-36. PubMed ID: 26961084 [TBL] [Abstract][Full Text] [Related]
7. Targeting the crosstalk between cytokine-induced killer cells and myeloid-derived suppressor cells in hepatocellular carcinoma. Yu SJ; Ma C; Heinrich B; Brown ZJ; Sandhu M; Zhang Q; Fu Q; Agdashian D; Rosato U; Korangy F; Greten TF J Hepatol; 2019 Mar; 70(3):449-457. PubMed ID: 30414862 [TBL] [Abstract][Full Text] [Related]
8. Profiling the dynamic expression of checkpoint molecules on cytokine-induced killer cells from non-small-cell lung cancer patients. Zhang L; Wang J; Wei F; Wang K; Sun Q; Yang F; Jin H; Zheng Y; Zhao H; Wang L; Yu W; Zhang X; An Y; Yang L; Zhang X; Ren X Oncotarget; 2016 Jul; 7(28):43604-43615. PubMed ID: 27283895 [TBL] [Abstract][Full Text] [Related]
9. Comparative study on anti-tumor immune response of autologous cytokine-induced killer (CIK) cells, dendritic cells-CIK (DC-CIK), and semi-allogeneic DC-CIK. Wang QJ; Wang H; Pan K; Li YQ; Huang LX; Chen SP; He J; Ke ML; Zhao JJ; Li JJ; Sun JC; Liang XT; Ma HQ; Chen YB; Xia JC Chin J Cancer; 2010 Jul; 29(7):641-8. PubMed ID: 20591215 [TBL] [Abstract][Full Text] [Related]
10. The dual-functional capability of cytokine-induced killer cells and application in tumor immunology. Zhang Q; Liu XY; Zhang T; Zhang XF; Zhao L; Long F; Liu ZK; Wang EH Hum Immunol; 2015 May; 76(5):385-91. PubMed ID: 25305457 [TBL] [Abstract][Full Text] [Related]
11. [Thymoglobulin efficiently expands cytokine-induced killer cells in a clinical-grade culture protocol]. Chen W; Lin D; Jiang Z; Yang Z; Song S; Zhou J; Zhou L; Sun Y; Yu H; Ma D Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jul; 30(7):681-5, 690. PubMed ID: 25001928 [TBL] [Abstract][Full Text] [Related]
12. Transfer of Her-2/neu specificity into cytokine-induced killer (CIK) cells with RNA encoding chimeric immune receptor (CIR). Yoon SH; Lee JM; Woo SJ; Park MJ; Park JS; Kim HS; Park MY; Sohn HJ; Kim TG J Clin Immunol; 2009 Nov; 29(6):806-14. PubMed ID: 19517218 [TBL] [Abstract][Full Text] [Related]
14. [Induction of dendritic cells from intra-operative lost blood and their effects on CIK against liver cancer cells in vitro]. DU Z; Zhao XL; Gao YT; Wu CX; Wang YJ; Zhu ZY; Sun Q; Fang SC Zhonghua Zhong Liu Za Zhi; 2008 Oct; 30(10):759-63. PubMed ID: 19173806 [TBL] [Abstract][Full Text] [Related]
16. In vitro analysis of the proliferative capacity and cytotoxic effects of ex vivo induced natural killer cells, cytokine-induced killer cells, and gamma-delta T cells. Niu C; Jin H; Li M; Xu J; Xu D; Hu J; He H; Li W; Cui J BMC Immunol; 2015 Oct; 16():61. PubMed ID: 26458364 [TBL] [Abstract][Full Text] [Related]
17. High Expression of Cannabinoid Receptor 2 on Cytokine-Induced Killer Cells and Multiple Myeloma Cells. Garofano F; Schmidt-Wolf IGH Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32471216 [TBL] [Abstract][Full Text] [Related]
18. Role of NKG2D in cytokine-induced killer cells against multiple myeloma cells. Lu X; Zhu A; Cai X; Jia Z; Han W; Ma L; Zhou M; Qian K; Cen L; Chen B Cancer Biol Ther; 2012 Jun; 13(8):623-9. PubMed ID: 22555808 [TBL] [Abstract][Full Text] [Related]
19. 2003-2013, a valuable study: Autologous tumor lysate-pulsed dendritic cell immunotherapy with cytokine-induced killer cells improves survival in stage IV breast cancer. Lin M; Liang S; Jiang F; Xu J; Zhu W; Qian W; Hu Y; Zhou Z; Chen J; Niu L; Xu K; Lv Y Immunol Lett; 2017 Mar; 183():37-43. PubMed ID: 28143792 [TBL] [Abstract][Full Text] [Related]
20. Polysaccharides from Hedyotis diffusa enhance the antitumor activities of cytokine-induced killer cells. Ma C; Wei Y; Liu Q; Xin Y; Cao G; Wang X; Yang P Biomed Pharmacother; 2019 Sep; 117():109167. PubMed ID: 31387180 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]